Pasithea Therapeutics Corp (KTTA)
6.92
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
7.05
+0.13
(+1.88%)
After-Hours: 20:00
Pasithea Therapeutics 1 Year Total Returns (Daily): 0.12% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 0.12% |
May 02, 2024 | -3.89% |
May 01, 2024 | 4.25% |
April 30, 2024 | -1.11% |
April 29, 2024 | -1.11% |
April 26, 2024 | -3.13% |
April 25, 2024 | -9.73% |
April 24, 2024 | -21.06% |
April 23, 2024 | -17.37% |
April 22, 2024 | -21.21% |
April 19, 2024 | -14.34% |
April 18, 2024 | -14.37% |
April 17, 2024 | -6.39% |
April 16, 2024 | -7.08% |
April 15, 2024 | -8.36% |
April 12, 2024 | -5.23% |
April 11, 2024 | -3.77% |
April 10, 2024 | 1.26% |
April 09, 2024 | 3.07% |
April 08, 2024 | 5.62% |
April 05, 2024 | 8.95% |
April 04, 2024 | 9.40% |
April 03, 2024 | -0.12% |
April 02, 2024 | -3.61% |
April 01, 2024 | -3.33% |
Date | Value |
---|---|
March 28, 2024 | -7.07% |
March 27, 2024 | -12.80% |
March 26, 2024 | -8.75% |
March 25, 2024 | -10.86% |
March 22, 2024 | -23.84% |
March 21, 2024 | -17.19% |
March 20, 2024 | -19.41% |
March 19, 2024 | -20.70% |
March 18, 2024 | -17.27% |
March 15, 2024 | -25.83% |
March 14, 2024 | -22.25% |
March 13, 2024 | -19.20% |
March 12, 2024 | -25.38% |
March 11, 2024 | -22.54% |
March 08, 2024 | -28.52% |
March 07, 2024 | -26.72% |
March 06, 2024 | -26.11% |
March 05, 2024 | -28.39% |
March 04, 2024 | -23.07% |
March 01, 2024 | -18.37% |
February 29, 2024 | -16.68% |
February 28, 2024 | -20.85% |
February 27, 2024 | -25.51% |
February 26, 2024 | -24.60% |
February 23, 2024 | -25.80% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-81.79%
Minimum
Nov 23 2022
9.40%
Maximum
Apr 04 2024
-51.82%
Average
-56.10%
Median
Jun 13 2023
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -27.23% |
AIM ImmunoTech Inc | -15.65% |
IGC Pharma Inc | 53.98% |
NovaBay Pharmaceuticals Inc | -90.79% |
Protalix BioTherapeutics Inc | -63.81% |